Industry Drug Development Portfolio Forecasting: Productivity, Risk, Innovation, Sustainability.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 2, p. 15, doi. 10.5912/jcb879
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2020 AND VI 25 AND IP 2
Results: 5
1
2
Bioenterprise Media Strategy 2020: Social Media, Mainstream Coverage, and a New Model of Trust.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 2, p. 43, doi. 10.5912/jcb884
- By:
- Publication type:
- Article
3
Using Real Options to Estimate the Pre-commercialisation Value of a Drought Tolerant Wheat Trait.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 2, p. 3, doi. 10.5912/jcb787
- By:
- Publication type:
- Article
4
Loss of Control of a Biosimilar Joint Venture and Remeasurement at Fair Value.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 2, p. 27, doi. 10.5912/jcb880
- By:
- Publication type:
- Article
5
Post Financial Crisis Transaction Trends of U.S. Biotechnology Firms.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 2, p. 53, doi. 10.5912/jcb885
- By:
- Publication type:
- Article